250 related articles for article (PubMed ID: 28122350)
1. Transcriptional suppression of microRNA-27a contributes to laryngeal cancer differentiation via GSK-3β-involved Wnt/β-catenin pathway.
Chen S; Sun YY; Zhang ZX; Li YH; Xu ZM; Fu WN
Oncotarget; 2017 Feb; 8(9):14708-14718. PubMed ID: 28122350
[TBL] [Abstract][Full Text] [Related]
2. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
Kong LY; Xue M; Zhang QC; Su CF
Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-27a Promotes the Proliferation and Invasiveness of Colon Cancer Cells by Targeting SFRP1 through the Wnt/β-Catenin Signaling Pathway.
Ba S; Xuan Y; Long ZW; Chen HY; Zheng SS
Cell Physiol Biochem; 2017; 42(5):1920-1933. PubMed ID: 28772260
[TBL] [Abstract][Full Text] [Related]
4. MiR-27a Facilitates Breast Cancer Progression via GSK-3β.
Chen H; Zhang Y; Cao X; Mou P
Technol Cancer Res Treat; 2020; 19():1533033820965576. PubMed ID: 33025840
[TBL] [Abstract][Full Text] [Related]
5. Wnt/β-catenin signaling pathway upregulates c-Myc expression to promote cell proliferation of P19 teratocarcinoma cells.
Zhang S; Li Y; Wu Y; Shi K; Bing L; Hao J
Anat Rec (Hoboken); 2012 Dec; 295(12):2104-13. PubMed ID: 22976998
[TBL] [Abstract][Full Text] [Related]
6. MiR-155 affects proliferation and apoptosis of bladder cancer cells by regulating GSK-3β/β-catenin pathway.
Dong ZC; Zhang D; Zhang XX; Yao ZQ; Wu H; Chen CH; Tian JQ
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5682-5690. PubMed ID: 31298320
[TBL] [Abstract][Full Text] [Related]
7. Target inhibition on GSK-3β by miR-9 to modulate proliferation and apoptosis of bladder cancer cells.
Dong ZC; Zhang D; Wang SB; Lin ZQ
Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3018-3026. PubMed ID: 29863246
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-124 represses wound healing by targeting SERP1 and inhibiting the Wnt/β-catenin pathway.
Zhang G; Song K; Yan H
Adv Clin Exp Med; 2019 Jun; 28(6):711-718. PubMed ID: 30740945
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-26b inhibits cell proliferation and cytokine secretion in human RASF cells via the Wnt/GSK-3β/β-catenin pathway.
Sun J; Yan P; Chen Y; Chen Y; Yang J; Xu G; Mao H; Qiu Y
Diagn Pathol; 2015 Jun; 10():72. PubMed ID: 26088648
[TBL] [Abstract][Full Text] [Related]
10. MiR-124 regulates osteoblast differentiation through GSK-3β in ankylosing spondylitis.
Tang SL; Huang QH; Wu LG; Liu C; Cai AL
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(20):6616-6624. PubMed ID: 30402833
[TBL] [Abstract][Full Text] [Related]
11. Investigations on the mechanism of progesterone in inhibiting endometrial cancer cell cycle and viability via regulation of long noncoding RNA NEAT1/microRNA-146b-5p mediated Wnt/β-catenin signaling.
Huang X; Zhong R; He X; Deng Q; Peng X; Li J; Luo X
IUBMB Life; 2019 Feb; 71(2):223-234. PubMed ID: 30452118
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-520e targets AEG-1 to suppress the proliferation and invasion of colorectal cancer cells through Wnt/GSK-3β/β-catenin signalling.
Lv S; Zhang J; He Y; Liu Q; Wang Z; Liu B; Shi L; Wu Y
Clin Exp Pharmacol Physiol; 2020 Jan; 47(1):158-167. PubMed ID: 31574178
[TBL] [Abstract][Full Text] [Related]
13. Silencing microRNA-27a inhibits proliferation and invasion of human osteosarcoma cells through the SFRP1-dependent Wnt/β-catenin signaling pathway.
Mu Y; Zhang L; Chen X; Chen S; Shi Y; Li J
Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31072914
[TBL] [Abstract][Full Text] [Related]
14. MiR-452 promotes an aggressive colorectal cancer phenotype by regulating a Wnt/β-catenin positive feedback loop.
Li T; Jian X; He H; Lai Q; Li X; Deng D; Liu T; Zhu J; Jiao H; Ye Y; Wang S; Yang M; Zheng L; Zhou W; Ding Y
J Exp Clin Cancer Res; 2018 Sep; 37(1):238. PubMed ID: 30253791
[TBL] [Abstract][Full Text] [Related]
15. The effect of miR-224 down-regulation on SW80 cell proliferation and apoptosis and weakening of ADM drug resistance.
Liang CQ; Fu YM; Liu ZY; Xing BR; Jin Y; Huang JL
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(21):5008-5016. PubMed ID: 29164556
[TBL] [Abstract][Full Text] [Related]
16. Targeting of GSK-3β by miR-214 to facilitate gastric cancer cell proliferation and decrease of cell apoptosis.
Li HL; Liang S; Cui JH; Han GY
Eur Rev Med Pharmacol Sci; 2018 Jan; 22(1):127-134. PubMed ID: 29364479
[TBL] [Abstract][Full Text] [Related]
17. MiR-155 affects renal carcinoma cell proliferation, invasion and apoptosis through regulating GSK-3β/β-catenin signaling pathway.
Wei RJ; Zhang CH; Yang WZ
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5034-5041. PubMed ID: 29228417
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-139-5p regulates C2C12 cell myogenesis through blocking Wnt/β-catenin signaling pathway.
Mi L; Li Y; Zhang Q; Zhao C; Peng Y; Yang G; Zheng X
Biochem Cell Biol; 2015 Feb; 93(1):8-15. PubMed ID: 25529604
[TBL] [Abstract][Full Text] [Related]
19. A silyl andrographolide analogue suppresses Wnt/β-catenin signaling pathway in colon cancer.
Reabroi S; Chairoungdua A; Saeeng R; Kasemsuk T; Saengsawang W; Zhu W; Piyachaturawat P
Biomed Pharmacother; 2018 May; 101():414-421. PubMed ID: 29501763
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-100 suppresses the migration and invasion of breast cancer cells by targeting FZD-8 and inhibiting Wnt/β-catenin signaling pathway.
Jiang Q; He M; Guan S; Ma M; Wu H; Yu Z; Jiang L; Wang Y; Zong X; Jin F; Wei M
Tumour Biol; 2016 Apr; 37(4):5001-11. PubMed ID: 26537584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
